Radiation Oncology

Uzm. Dr. Kımıa Çepni

Doctor and researcher Başakşehir Çam ve Sakura Şehir Hastanesi İstanbul
Lung NeoplasmsUterine Cervical Neoplasms
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Lung Neoplasms 2 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Uterine Cervical Neoplasms 2 publications

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyRadiation Oncologysaglik.gov.trFrom source
  • InstitutionBaşakşehir Çam ve Sakura Şehir Hastanesisaglik.gov.trFrom source
  • Area of workLung NeoplasmsExtracted from 2 publications · Model version —From source
  • Publications27 publicationsOpenAlex, ORCIDFrom source
  • ORCID0000-0001-7467-6917ORCIDFrom source
  • Last synchronised5 November 2026 10:37https://camsakurasehir.saglik.gov.tr/TR-1233239/gorev-yapan-hekimlerimiz.html#kimia-cepnisaglik.gov.tr

Scientific work

Publications on Lung Neoplasms

27 publications

  1. Effects of rectal retractor use on dosimetric parameters, treatment-related adverse events, and clinical outcomes of cervical cancer brachytherapy: A retrospective tertiary-centre study

    Clinical and Translational Radiation Oncology, 2026

    DOI 10.1016/j.ctro.2026.101302 PMID 42871204 Open-access full textSource: OpenAlex

  2. Association of Pretreatment Hemoglobin and Lymphocyte Levels with Survival Outcomes in Cervical Cancer Patients Undergoing Chemoradiotherapy

    Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi, 2026

    DOI 10.38136/jgon.1967510 Open-access full textSource: ORCID

  3. Impact of Response Rates on Overall Survival Following Chemoradiotherapy with or Without Surgery in Esophageal Cancer

    Cerrahpaşa Medical Journal, 2026

    DOI 10.5152/cjm.2026.25079 Open-access full textSource: ORCID

  4. Efficacy and Safety of Radiotherapy in Head and Neck Paragangliomas: A Retrospective 23-Year Analysis

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15031062 PMID 41682742 1 citation (Europe PMC) Open-access full textSource: ORCID

  5. Predictive Role of Pre-Radiotherapy D-Dimer and Inflammatory Markers in Monitoring Outcomes After Treatment in Hormone-Positive Breast Cancer: A Retrospective Cohort Study

    Diagnostics, 2026

    DOI 10.3390/diagnostics16040582 PMID 41750730 Open-access full textSource: ORCID

  6. Pretreatment Neutrophil-to-Lymphocyte Ratio as an Independent Prognostic Biomarker in Esophageal Cancer Following Neoadjuvant Chemoradiotherapy

    Kasav international journal of health sciences., 2026

    DOI 10.29228/kijhs.95619 Source: ORCID

  7. A multidimensional benchmarking framework for large language models in oncologic decision making

    Scientific Reports, 2026

    DOI 10.1038/s41598-026-61195-1 PMID 42481610 3 citations (OpenAlex) Open-access full textSource: OpenAlex

  8. Prognostic Significance of Lymphocyte Percentage and IL-6 Level in Patients Undergoing Radiotherapy for Advanced Lung Cancer

    Bezmialem Science, 2026

    DOI 10.14235/bas.galenos.2025.98624 Open-access full textSource: OpenAlex

  9. Comparative validation of prognostic indices in brain metastases receiving cranial radiotherapy

    Oncology in Clinical Practice, 2025

    DOI 10.5603/ocp.108320 Open-access full textSource: ORCID

  10. Prognostic value of D-dimer in treatment and follow up for patients who underwent radiotherapy in advanced lung cancer

    Plos One, 2025

    DOI 10.1371/journal.pone.0333085 PMID 40986549 Open-access full textSource: ORCID

View all 27 publications